Profile avatar
drmootravardhak.bsky.social
Nephrologist (kidney doctor), Director of post-AKI care, Clinician-researcher-educator-father. Home dialysis champion. Views are personal, not employer’s.
89 posts 383 followers 72 following
Getting Started
Active Commenter

Lately, I don’t enjoy @nkf-professionals.bsky.social or @asnkidney.bsky.social meetings as much as @renalphysicians.bsky.social First 2 are about “cool drugs that cost a million and improve 1% of patients by 30%” rather than “How to survive & thrive as a burnt out specialty no one wants to join”

“If you have abdominal pain on the right, upper or lower, around belly button or lower, severe, throbbing, in one spot or moving around, go to the ER (not PCP or urgent care)”- HuffPost Next article coming soon: “Crisis: How ER visits drive up healthcare costs” www.huffpost.com/entry/stomac...

“officials regularly ignore the rankings, leapfrogging over hundreds or even thousands of people when they give out kidneys, livers, lungs and hearts. These organs often go to recipients who are not as sick, have not been waiting nearly as long…” www.nytimes.com/interactive/...

Adult nephrologists, with your hospital administration and state malpractice environment, would you feel comfortable dialyzing a kid coming in with toxic ingestion if asked to? Why/ why not? #askrenal

Once upon a time, some villagers came across a large, ornate wooden box in the local woods. On the side of the box was a message: “Whatever money you put in this box will, in future, grow to become 2.5 times larger.” 1/

Interesting thread by James Heather about the indirect rate caps by the #NIH . It is not the first time this comes up e.g. both the Obama and the 1st DJT admin tried to cap them (with fierce discussions on Twitter back in 2017).

US nephrologists, while discussing incoming fellow quality with regional faculty, most seem to be disappointed (big picture, everyone has many bright spots). New meds but worries about doc quality. How do you see the future of nephrology in 10 years? Stable/ascendant/declining?Why? #askrenal#nephsky

Things used in nephrology without evidence or despite evidence of futility: Urine eosinophils Urine anion gap Albumin correction for anion gap and calcium Slow correction for mild-moderate hyponatremia Vitamin D for renal bone disease Anything else to add to list? #askrenal

“Even mildly elevated serum phosphate levels of >3.5 or >4.0 mg/dL should receive attention” What do we mean by attention? Identify phos as risk factor when stratifying-maybe. But pretty please don’t let it mean use phos binders to lower phos below 4 in ADPKD